Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/07/25
End: 10/31/40
Due: 10/31/41
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 12/31/28
Due: 12/31/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies | NCT06906380 | ARCE Therapeutics, Inc. | user2@example.com | None | 2025-05-07 | 2040-10-31 | 2041-10-31 | - | - | 2025-07-14 |
| Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS | NCT06680752 | ARCE Therapeutics, Inc. | user2@example.com | None | 2025-05-31 | 2028-12-31 | 2029-12-31 | - | - | 2025-07-14 |